[Skip to Content]
[Skip to Content Landing]
Article
November 1981

Prolongation of Anti-inflammatory Effect of Prednisolone AcetateInfluence of Formulation in High-Viscosity Gel

Author Affiliations

From the Departments of Ophthalmology (Drs Kupferman and Leibowitz and Mr Ryan) and Pharmacology (Dr Kupferman), Boston University School of Medicine.

Arch Ophthalmol. 1981;99(11):2028-2029. doi:10.1001/archopht.1981.03930020904017
Abstract

• Prednisolone acetate was formulated in a high-viscosity carboxypolymethylene gel at concentrations of 0.125% and 1.0%. The ability of these gel preparations to suppress inflammation in the cornea was assessed and compared with the anti-inflammatory capabilities of conventional commercially available prednisolone acetate ophthalmic suspensions. When administered hourly, the gel formulations produced no greater anti-inflammatory effect than the conventional suspensions. However, the gel formulations were equal in effect to the suspensions and maintained their effects considerably longer than did the suspensions. When applied at intervals up to and including four hours, there was no falloff in effect; the gel demonstrated a level of anti-inflammatory effectiveness that could not be distinguished from hourly administration of the suspension.

References
1.
Leibowitz HM, Kupferman A:  Optimal frequency of topical prednisolone administration . Arch Ophthalmol 1979;97:2154-2156.Article
2.
Schoenwald RD, Boltralik JJ:  A bioavailability comparison in rabbits of two steroids formulated as high viscosity gels and reference aqueous preparations . Invest Ophthalmol Vis Sci 1979;18:61-66.
3.
Leibowitz HM, Lass JH, Kupferman A:  Quantitation of inflammation in the cornea . Arch Ophthalmol 1974;92:427-430.Article
4.
Leibowitz HM, Kupferman A:  Anti-inflammatory effectiveness in the cornea of topically administered prednisolone . Invest Ophthalmol Vis Sci 1974;13:757-763.
5.
Cox WV, Kupferman A, Leibowitz HM:  Topically applied steroids in corneal disease: I. The role of inflammation in stromal absorption of dexamethasone . Arch Ophthalmol 1972;88:308-313.Article
6.
Snedecor GW: Statistical Methods Applied to Experiments in Agriculture and Biology , ed 5. Ames, Iowa, Iowa State College, 1956.
7.
Cox WV, Kupferman A, Leibowitz HM:  Topically applied steroids in corneal disease: II. The role of drug vehicle in stromal absorption of dexamethasone . Arch Ophthalmol 1972;88:549-552.Article
8.
Goldberg I, Ashburn FS Jr, Kass MA, et al:  Efficacy and patient acceptance of pilocarpine gel . Am J Ophthalmol 1979;88:843-846.
×